Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Buchanan

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Schizophrenia Bulletin|January 1, 1997
Evaluation of treatment-resistant schizophreniaR R Conley, R W Buchanan
Biological Psychiatry|August 1, 1995
Neuroleptic-induced emesis: a new indication for clozapine?J R Bustillo, R W Buchanan
The American Journal of Psychiatry|January 1, 1988
Significance and meaning of neurological signs in schizophreniaD W Heinrichs, R W Buchanan
International Clinical Psychopharmacology|May 1, 1996
Negative symptoms: diagnosis, treatment and prognosisR W Buchanan, J M Gold
Psychiatry Research|March 1, 1989
The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophreniaR W Buchanan, D W Heinrichs
The Journal of Urology|March 19, 2010
The use of absorbable gauze (oxidized cellulose) in urological surgeryJ K DeVRIES, R W BUCHANAN
Biological Psychiatry|August 1, 1994
Stability of neurological signs with clozapine treatmentR W Buchanan, P Koeppl, A Breier
Schizophrenia Research|May 18, 2001
A five-year followup study of deficit and nondeficit schizophreniaC Tek, B Kirkpatrick, R W Buchanan
Biological Psychiatry|October 1, 1993
Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophreniaA Breier, B Kirkpatrick, R W Buchanan
The American Journal of Psychiatry|March 30, 2000
Neurological signs and the heterogeneity of schizophreniaC Arango, B Kirkpatrick, R W Buchanan
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Schizophrenia Bulletin|January 1, 1997
Evaluation of treatment-resistant schizophreniaR R Conley, R W Buchanan
Biological Psychiatry|August 1, 1995
Neuroleptic-induced emesis: a new indication for clozapine?J R Bustillo, R W Buchanan
The American Journal of Psychiatry|January 1, 1988
Significance and meaning of neurological signs in schizophreniaD W Heinrichs, R W Buchanan
International Clinical Psychopharmacology|May 1, 1996
Negative symptoms: diagnosis, treatment and prognosisR W Buchanan, J M Gold
Psychiatry Research|March 1, 1989
The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophreniaR W Buchanan, D W Heinrichs
The Journal of Urology|March 19, 2010
The use of absorbable gauze (oxidized cellulose) in urological surgeryJ K DeVRIES, R W BUCHANAN
Biological Psychiatry|August 1, 1994
Stability of neurological signs with clozapine treatmentR W Buchanan, P Koeppl, A Breier
Schizophrenia Research|May 18, 2001
A five-year followup study of deficit and nondeficit schizophreniaC Tek, B Kirkpatrick, R W Buchanan
Biological Psychiatry|October 1, 1993
Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophreniaA Breier, B Kirkpatrick, R W Buchanan
The American Journal of Psychiatry|March 30, 2000
Neurological signs and the heterogeneity of schizophreniaC Arango, B Kirkpatrick, R W Buchanan
Pageof 10